UPDATE : Thursday, March 22, 2018
Theragen ETEX, My23 to popularize gene analysis service
Theragen ETEX Bio Institute said Thursday that it has signed a memorandum o...
by Lee Han-soo  |  2018-03-22 16:14
Anticoagulant latecomer Lixiana outrivals Eliquis
The competition between No.2 and No.3 next-generation anticoagulant is heat...
by So Jae-hyeon  |  2018-03-22 16:12
Ajou University Hospital adopts HyperArc radiotherapy
The Ajou University Hospital said it has become the first in Asia to adopt ...
by Kwak Sung-sun  |  2018-03-22 15:43
2 professors in legal battle over textbook authorship
Ahn Hee-chang, a plastic surgery professor at Hanyang University Hospital, ...
by Song Soo-youn  |  2018-03-22 14:56
Yuyu to start clinical trials on dry eye treatment
Yuyu Pharmaceuticals said Thursday that it has received approval from the M...
by Lee Han-soo  |  2018-03-22 14:34
Daewoong to promote AstraZeneca’s diabetes treatment
Daewoong Pharmaceutical and AstraZeneca Korea have signed a co-promotion pa...
by Lee Han-soo  |  2018-03-22 11:25
Daiichi Sankyo Korea to co-market Kuhnil’s dyslipidemia treatment
Daiichi Sankyo Korea said Thursday that it has signed a strategic partnersh...
by Lee Han-soo  |  2018-03-22 11:25
European urology group praises Gemvax & KAEL’s research paper
Gemvax & KAEL said Wednesday that the European Association of Urology (EAU)...
by Lee Han-soo  |  2018-03-22 11:24
Roche’s Tecentriq gets reimbursement as 2nd line treatment for 2 cancers
Roche Korea (CEO: Matt Sause) said Wednesday that the country’s first anti ...
by Marian Chu  |  2018-03-21 18:27
Why is biopharmaceutical outlook rosy, despite bubble concern?
Celltrion Inc. and SillaJen are two representative pharmaceutical companies...
by Park Gi-taek  |  2018-03-21 16:04
JW Pharma gets orphan drug status for Roche’s hemophilia treatment
JW Pharmaceutical said Wednesday that the Ministry of Food and Drug Safety ...
by Lee Han-soo  |  2018-03-21 15:47
Daewoong promotes botulinum toxin Nabota in Dubai
Daewoong Pharmaceutical has begun pushing international marketing activitie...
by So Jae-hyeon  |  2018-03-21 15:47
Genexine gets FDA nod for trials on immunotherapeutic agent
Genexine said Tuesday that it has received approval to go ahead with the ph...
by Lee Han-soo  |  2018-03-21 11:40
4 drugmakers’ profits turn to losses
Among KOSDAQ-listed pharmaceutical companies, four firms’ operating profits...
by Nam Doo-hyun  |  2018-03-21 11:38
Access Bio Korea dedicates local factory
Access Bio Korea, a subsidiary of Access Bio, dedicated its first local fac...
by Lee Han-soo  |  2018-03-21 10:35
Merck Korea says study confirms safety, efficacy of heart drug in Asian patients
Merck Biopharma Korea said that its coronary heart disease drug Concor (bis...
by Marian Chu  |  2018-03-20 19:42
Seoul to punish drugmakers for offering rebates via outsourced firms
The government has toughened up regulations on outsourced pharmaceutical co...
by So Jae-hyeon  |  2018-03-20 16:30
Genexine’s clinical trial on persistent growth hormone running smoothly
Genexine and Handok have announced the intermediate results of phase 2 clin...
by Lee Han-soo  |  2018-03-20 16:19
Researchers unveil indicator that can predict strokes
Researchers at Seoul National University Hospital (SNUH) and Korea Universi...
by Lee Han-soo  |  2018-03-20 14:47
Foreigners buy SillaJen, Samsung BioLogics, dump Celltrion
Foreign investors net purchased shares of SillaJen and Samsung BioLogics, a...
by Nam Doo-hyun  |  2018-03-20 12:01
Back to Top